China Minsheng Banking Corp., Ltd.
China Minsheng Banking Corp., Ltd. (CGMBF) Financial Performance & Income Statement Overview
Analyze China Minsheng Banking Corp., Ltd. (CGMBF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
China Minsheng Banking Corp., Ltd. (CGMBF) Income Statement & Financial Overview
View the income breakdown for China Minsheng Banking Corp., Ltd. CGMBF across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $25.95B | $34.63B | $34.53B | $74.11B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $25.95B | $34.63B | $34.53B | $74.11B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $10.11B | $16.97B | $18.61B | $10.52B |
| Operating Expenses | $10.11B | $17.96B | $34.53B | $10.10B |
| Total Costs & Expenses | $10.11B | $17.96B | $34.53B | $66.05B |
| Interest Income | $0.00 | $60.87B | $62.25B | $63.00B |
| Interest Expense | $0.00 | $35.93B | $37.09B | $38.68B |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $2.20B |
| EBITDA | $0.00 | $0.00 | $8.58B | $10.42B |
| EBITDA Ratio | $0.00 | $0.00 | $0.25 | $0.14 |
| Operating Income | $15.85B | $16.67B | -$37.09B | -$179.00M |
| Operating Income Ratio | $0.61 | $0.48 | -$1.07 | -$0.002 |
| Other Income/Expenses (Net) | -$1.60B | -$14.65B | $45.67B | $259.00M |
| Income Before Tax | $14.25B | $2.03B | $8.58B | $8.22B |
| Income Before Tax Ratio | $0.55 | $0.06 | $0.25 | $0.11 |
| Income Tax Expense | $1.46B | $22.00M | $574.00M | -$999.00M |
| Net Income | $12.74B | $1.81B | $8.01B | $9.04B |
| Net Income Ratio | $0.49 | $0.05 | $0.23 | $0.12 |
| EPS | $0.29 | $0.04 | $0.18 | $0.21 |
| Diluted EPS | $0.29 | $0.04 | $0.18 | $0.21 |
| Weighted Avg Shares Outstanding | $43.94B | $16.39B | $43.78B | $43.78B |
| Weighted Avg Shares Outstanding (Diluted) | $43.94B | $22.70B | $43.78B | $43.78B |
The company's financials show resilient growth, with revenue advancing from $74.11B in Q2 2024 to $25.95B in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 100% in Q2 2024. Operating income hit $15.85B last quarter, sustaining a consistent 61% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $0.00. Net income rose to $12.74B, while earnings per share reached $0.29. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan